XML 21 R2.htm IDEA: XBRL DOCUMENT v3.6.0.2
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Dec. 31, 2016
Dec. 31, 2015
Current assets:    
Cash and cash equivalents $ 342.4 $ 267.1
Short-term investments 157.9 201.2
Accounts receivable, net 243.9 234.7
Inventories 440.4 422.0
Other current assets 91.3 106.5
Total current assets 1,275.9 1,231.5
Property, plant and equipment, net 239.1 231.1
Goodwill 130.6 130.6
Intangible assets, net 69.7 74.7
Deferred tax assets 76.5 53.0
Other long-term assets 16.6 9.1
Total assets 1,808.4 1,730.0
Current liabilities:    
Current portion of long-term debt 20.1 0.6
Accounts payable 86.1 72.1
Customer advances 149.0 178.3
Other current liabilities 269.5 303.5
Total current liabilities 524.7 554.5
Long-term debt 391.6 265.2
Long-term deferred revenue 46.8 44.4
Deferred tax liabilities 10.1 9.5
Accrued pension 102.5 91.6
Other long-term liabilities 39.6 31.9
Commitments and contingencies (Note 14)
Shareholders' equity:    
Preferred stock, $0.01 par value 5,000,000 shares authorized, none issued or outstanding at December 31, 2016 and 2015
Common stock, $0.01 par value 260,000,000 shares authorized, 170,552,890 and 169,644,644 shares issued and 159,854,695 and 165,354,180 outstanding at December 31, 2016 and 2015, respectively 1.7 1.7
Treasury stock at cost, 10,698,195 and 4,290,527 shares at December 31, 2016 and 2015, respectively (249.3) (90.9)
Additional paid-in capital 124.7 102.1
Retained earnings 885.2 757.4
Accumulated other comprehensive loss (75.9) (44.2)
Total shareholders' equity attributable to Bruker Corporation 686.4 726.1
Noncontrolling interest in consolidated subsidiaries 6.7 6.8
Total shareholders' equity 693.1 732.9
Total liabilities and shareholders' equity $ 1,808.4 $ 1,730.0